| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3921897 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2006 | 4 Pages |
Abstract
Although, no statistical difference in terms of DNA damage levels between tibolone plus alendronate as opposed to alendronate alone was found, an increase in DNA damage levels was observed in Groups 1 and 2 compared with the control group. Consequently, it can be asserted that the frequency of DNA damage in postmenopausal women with osteoporosis increases under alendronate treatment with or without tibolone.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Merih Bayram, Canan Soyer, Ela Kadioglu, Semra Sardas,